Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients
with chronic thromboembolic pulmonary disease with and without pulmonary hypertension …

Pulmonary arterial hypertension (PAH) is a rare pulmonary vascular disorder, wherein mean
systemic arterial pressure (mPAP) becomes abnormally high because of aberrant changes …

Background Detection of pulmonary perfusion defects is the recommended approach for
diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This is currently …

Pulmonary hypertension (PH) is characterized by a progressive increase in pulmonary
arterial pressure and pulmonary vascular resistance. In a short time, it leads to right …

Increasing evidence suggests that mitochondrial dysfunction in pulmonary endothelial cells
(ECs) plays a causative role in the initiation and progression of pulmonary hypertension …

Pulmonary hypertension (PH) is defined by the presence of a mean pulmonary arterial
pressure> 20 mmHg. Current guidelines describe five groups of PH with shared …

Abstract Background and Aims Interventional studies in pulmonary arterial hypertension
completed to date have shown to be effective in symptomatic patients with significantly …

Pulmonary hypertension (PH) associated with left heart diseases (PH-LHD), also termed
group 2 PH, represents the most common form of PH. It develops through the passive …

Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate
despite advances in diagnostic and therapeutic strategies. In recent years, significant …

Background Chronic obstructive pulmonary disease (COPD) is the third most common
cause of death around the world. The affected patients suffer not only from impaired lung …